Treatment for improving the use of dietary sugar for energy purposes

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11032021
APP PUB NO 20190280799A1
SERIAL NO

16259155

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to the use of a very low dosage form of abscisic acid (ABA) or an in vivo hydrolysable conjugate thereof, preferably ABA-glucosyl ester (ABA-GE), for nutracentic/therapeutic use for controlling and/or preventing hyperglycaemia and weight gain in response to sugar intake with a reduction in insulin secret and an increase in muscle performance.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
DERMAPHARM AKTIENGESELLSCHAFTLIL-DAGOVER-RING 7 GRÜNWALD 82031

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Benatti, Umberto Genoa, IT 8 14
De, Flora Antonio Genoa, IT 7 12
Del, Re Giovanni L'aquila, IT 4 13
Magnone, Mirko Genoa, IT 4 4
Zocchi, Elena Genoa, IT 6 4

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Dec 8, 2028
11.5 Year Payment $7400.00 $3700.00 $1850.00 Dec 8, 2032
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00